GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 166 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,476,000 | – | 168,323 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 500,000 | $6,765,000 | 5.83% |
Gruss & Co., LLC | 200,000 | $2,706,000 | 3.07% |
First Light Asset Management, LLC | 150,076 | $2,031,000 | 1.37% |
Curi RMB Capital, LLC | 1,032,369 | $13,968,000 | 0.88% |
Camber Capital Management LP | 908,100 | $12,287,000 | 0.80% |
CADIAN CAPITAL MANAGEMENT, LP | 887,500 | $12,008,000 | 0.36% |
PARNASSUS INVESTMENTS, LLC | 2,118,127 | $28,658,000 | 0.25% |
Visium Asset Management, LP | 786,468 | $10,641,000 | 0.16% |
PUTNAM INVESTMENTS LLC | 5,198,367 | $70,333,000 | 0.15% |
Capital Impact Advisors, LLC | 13,933 | $189,000 | 0.14% |